CD274 and neoplasm: Furthermore, a study by Kim et al. 2021 investigated the combination of PDT, a PD-1/PD-L1 immune checkpoint inhibitor, and the rho-kinase (ROCK) inhibitor ripasudil, resulting in significant tumor growth inhibition in both primary and metastatic lesions [45].